SEOUL, Aug. 7 (Korea Bizwire) — South Korea has approved first phase clinical trials for a potential treatment material for the novel coronavirus, the Ministry of Food and Drug Safety said Friday. The material to be tested is GX-17 being developed by local biotech firm Genexine, the government agency said. GX-17 is a so-called repositioning [...]
SEOUL, Aug. 5 (Korea Bizwire) — Nafamostat, a drug used to treat acute pancreatitis and prevent blood clotting for patients receiving blood dialysis, was found to be effective against COVID-19, the disease caused by the novel coronavirus. Professors Rhee Ji-young and Jang Suk-bin from Dankook University Hospital published an article detailing the use of nafamostat [...]
SEOUL, June 26 (Korea Bizwire) — South Korea has approved 15 candidates for coronavirus treatment drugs and vaccines for clinical trials as it steps up efforts to combat the coronavirus pandemic, the Ministry of Food and Drug Safety said Friday. The candidate materials include two that may be developed into vaccines and 13 that show [...]
SEOUL, June 17 (Korea Bizwire) — Clinical trials in South Korea to evaluate the potential therapeutic efficacy of an anti-malaria drug, chloroquine, for the treatment of the novel coronavirus have been halted, hospital officials said Wednesday. Two major general hospitals in Seoul — Asan Medical Center and Gangnam Severance Hospital — have recently ceased their [...]
SEOUL, March 27 (Korea Bizwire) — The South Korean drug safety watchdog said Friday it has approved five clinical trials of existing drugs that could be used to treat COVID-19 patients as part of efforts to combat the disease ravaging the world. Three of the clinical trials involve the Ebola drug Remdesivir and will be [...]
SEOUL, Jan. 13 (Korea Bizwire) — Major South Korean pharmaceutical companies are ramping up the phase-three clinical trials of their key products in China as they seek to tap deeper into the world’s second largest bio market. Samsung Bioepis Co. said it is awaiting approval from Chinese health authorities for the final stage of clinical [...]
SEOUL, Jan. 16 (Korea Bizwire) — South Korea ranked sixth in the number of clinical trials last year, up two places from 2016, a new study has found. Data provided by the U.S. government agency National Institutes of Health (NIH) has revealed that while South Korea ranked sixth, Seoul was named the city with the [...]